Results 291 to 300 of about 95,583 (387)
Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a Department of Veterans Affairs quality improvement intervention. [PDF]
Yun S+5 more
europepmc +1 more source
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Aleksandra Novikov, V. Vallon
semanticscholar +1 more source
ABSTRACT Aims Anaemia is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and associated with poor clinical outcomes. While renin–angiotensin system blockers reduce haemoglobin, little is known about the effect of mineralocorticoid receptor antagonists on haemoglobin and in patients with anaemia.
Misato Chimura+23 more
wiley +1 more source
Sugar flux and signaling in plant-microbe interactions
Bezrutczyk, M.+11 more
core +1 more source
The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt+2 more
wiley +1 more source
The cardio-renal-metabolic role of the nod-like receptor protein-3 and senescence-associated secretory phenotype in early sodium/glucose cotransporter-2 inhibitor therapy in people with diabetes who have had a myocardial infarction. [PDF]
Shah MU+4 more
europepmc +1 more source
The Functional Unit of the Renal Type IIa Na+/Pi Cotransporter Is a Monomer
Katja Köhler+4 more
openalex +1 more source
SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index. [PDF]
Lee YS+6 more
europepmc +1 more source